Aristotle Capital Boston, LLC
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 1633911
BOSTON, MA
Position in SUPN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$10,497,928
-$1,156,871 QoQ
Shares Held
203,094
-13.4% QoQ
Ownership
0.350%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 78.14361822604312.ToString("F0")%
Shared 0.ToString("F0")%
None 21.856381773956887.ToString("F0")%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Aristotle Capital Boston, LLC holds $29,799,437 across 3 Drug Manufacturers - Specialty & Generic names. SUPN ranks #2 (35.2% of the industry book) .
All Filings in SUPN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,497,928 | 203,094 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $11,654,799 | 234,503 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $14,588,996 | 305,273 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $25,480,610 | 808,395 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $28,580,532 | 872,688 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $38,903,386 | 1,075,868 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $37,235,966 | 1,194,226 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $32,184,690 | 1,203,166 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $38,880,147 | 1,139,846 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $33,565,422 | 1,159,828 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $32,752,636 | 1,187,981 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $34,928,126 | 1,161,947 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $41,851,048 | 1,155,149 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $40,195,845 | 1,126,881 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $39,183,169 | 1,157,553 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $36,663,040 | 1,267,740 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $40,660,725 | 1,258,067 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $37,496,027 | 1,285,872 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $35,153,967 | 1,318,109 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $32,688,295 | 1,061,653 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $25,480,810 | 973,293 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $25,704,110 | 1,021,626 | Shares | Sole | 2021-02-22 | |
| 2020-09-30 | $22,349,899 | 1,072,452 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $24,411,152 | 1,027,838 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $13,324,095 | 740,639 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||